MedPath

Usability of Cognitive Improvement Software in Cognitively Impaired Patients: Pilot Study

Active, not recruiting
Conditions
Mild Cognitive Impairment
Interventions
Other: Cognitive improvement software
Registration Number
NCT05634161
Lead Sponsor
Seoul National University Hospital
Brief Summary

Usability study of software application that provide digitized cognitive intervention therapy for cognitively impaired patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Male and Female patients, 55~85 years
  • Adequate vision, hearing and speaking for neuropsychological testing
  • No difficulty in using mobile application using smartphone
  • Patients with subjective memory complaints, confirmed by informants
  • Cognitive impairment of SD 1 or greater from the age-adjusted normal range in Memory domain in CERAD-NP battery
  • Global CDR 0.5 ~ 1
  • Korean speaker
  • Have an identified trial partner
  • All subjects signed written consent
Exclusion Criteria
  • Those unable to provide consent
  • History of transient ischemic attack, stroke, brain tumor
  • History of diagnosis of major depression
  • Symptoms that may interfere with the subject's testing procedure
  • Cerebral hemorrhage
  • Central nervous system infections
  • Prohibited concomitant medication
  • Known or suspected history of drug or alcohol abuse

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Cognitive Improvement softwareCognitive improvement softwareUsability assessment of cognitive improvement software
Primary Outcome Measures
NameTimeMethod
Usability: Based on scenariosSingle-point evaluation (baseline)
Secondary Outcome Measures
NameTimeMethod
Changes in ADCS-ADLAfter 12 weeks of system usage
Changes in self-reported quality of lifeAfter 12 weeks of system usage
Changes in blood biomarkerAfter 12 weeks of system usage
Usability: Based on user surveySingle-point evaluation (baseline)
Usability: Based on hemodynamic responsesSingle-point evaluation (baseline)
Changes in Adas-cogAfter 12 weeks of system usage

Trial Locations

Locations (1)

Seoul Metropolitan Government Seoul National University Boramae Medical Center

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath